Ali Al-Janabi

11PUBLICATIONS
20CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Traditional, complementary and integrative medicine not elsewhere classifiedAllergyMajor global burdens of diseasePharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 25, 2023
The effect of immunomodulators on seroconversion after BNT162b2 and AZD1222 vaccines in patients with immune-mediated inflammatory diseases: a prospective cohort study.

Ali Al-Janabi, Amelle Ra, Zoe Littlewood

|Jan 15, 2023
Global Guidelines in Dermatology Mapping Project (GUIDEMAP): a systematic review of alopecia areata clinical practice guidelines.

Leila Asfour, Marianne De Brito, Ali Al-Janabi

|Feb 12, 2022
Paradoxical eczema in patients with psoriasis receiving biologics: a case series.

Ali Al-Janabi, Amy Charlotte Foulkes, Christopher Ernest Maitland Griffiths

|May 13, 2021
Antibody responses to single-dose SARS-CoV-2 vaccination in patients receiving immunomodulators for immune-mediated inflammatory disease.

A Al-Janabi, Z Littlewood, C E M Griffiths

|May 03, 2021
Global Guidelines in Dermatology Mapping Project (GUIDEMAP): a scoping review of dermatology clinical practice guidelines.

W Y Haw, A Al-Janabi, B W M Arents

|Sep 16, 2020
Update on risankizumab for the treatment of moderate to severe psoriasis.

A Al-Janabi, R B Warren

Pageof 2

Frequent Collaborators

5 joint publications

Zenas Zee Ngai Yiu

4 joint publications

Richard Bruce Warren

3 joint publications

Christopher Ernest Maitland Griffiths

2 joint publications

William W Y Haw